Similar articles

• [Immunity and hypersensitivity in Hodgkin's lymphoma].

  Leoni P, Marchegiani G, Montillo M, Centurioni R, Montroni M, Danieli G. Leoni P, et al. Minerva Med. 1982 May 12;73(20):1361-9. Minerva Med. 1982. PMID: 6210855 Review. Italian. No abstract available.
• Immunodeficiencies in Hodgkin's Disease. Part II: B cell immunity, complement systems and phagocytic cell systems.

  Gupta S. Gupta S. Clin Bull. 1981;11(3):110-9. Clin Bull. 1981. PMID: 7039866 Review. No abstract available.
• B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease.

  Gajl-Peczalska KJ, Hansen JA, Bloomfield CD, Good RA. Gajl-Peczalska KJ, et al. J Clin Invest. 1973 Dec;52(12):3064-73. doi: 10.1172/JCI107505. J Clin Invest. 1973. PMID: 4201499 Free PMC article.
• In vitro characterization of T and B lymphocytes in chronic lymphatic leukemia and Hodgkin's disease.

  Tursi A, Ferrannini A, Losito G. Tursi A, et al. Boll Ist Sieroter Milan. 1974;53(1):suppl:306. Boll Ist Sieroter Milan. 1974. PMID: 4604590 No abstract available.
• [Immunological aspects of Hodgkin's disease].

  Bianchini E. Bianchini E. Minerva Med. 1975 Feb 3;66(8):365-70. Minerva Med. 1975. PMID: 1078722 Italian.